BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Doxazosin Mesylate

A prazosin-related compound that is a selective alpha-1-adrenergic blocker.

24+ PubMed studies analyzed · 3 RCTs · Evidence Score: 41.3

Research Domains

Doxazosin Mesylate has been studied across 5 research domains including 🫁 Liver & Detox, 🧠 Focus & Attention, ❤️ Cardiovascular, 🏋️ Muscle & Hypertrophy, 🦴 Bone & Joint. The primary research focus is 🫁 Liver & Detox with 17% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Doxazosin Mesylate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

vinpocetine
10 shared targets
Salmeterol
9 shared targets
Loxapine
8 shared targets
Cefoxitin
4 shared targets
Quinestrol
7 shared targets
amlexanox
8 shared targets
Polidocanol
7 shared targets
Nicardipine
9 shared targets
Cefmenoxime
3 shared targets
clofilium
9 shared targets
Loading evidence profile...

This evidence profile for Doxazosin Mesylate is generated deterministically from 24 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.